Expression, localization, and erythrocyte binding activity of Plasmodium yoelii merozoite surface protein-8

Molecular and Biochemical Parasitology

Volumn 149, Issue 2, 2006, Pages 231-241

  Shi, Qifang ^a   Cernetich Ott, Amy ^a   Lynch, Michelle M ^a   Burns Jr , James M ^a  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

Erythrocyte invasion; Malaria; Merozoite surface proteins; MSP 8; Plasmodium yoelii

Indexed keywords

MEROZOITE SURFACE PROTEIN 8; PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ENZYME BINDING; ERYTHROCYTE; EVALUATION; IMMUNIZATION; IMMUNOFLUORESCENCE; MOUSE; NONHUMAN; PLASMODIUM YOELII; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; SURFACE PROPERTY; TROPHOZOITE;

ANIMALS; ANTIGENS, PROTOZOAN; ERYTHROCYTES; IMMUNIZATION; MALARIA; MEROZOITE SURFACE PROTEIN 1; MICE; MICE, INBRED BALB C; PLASMODIUM YOELII; PROTOZOAN PROTEINS; RETICULOCYTES;

PLASMODIUM YOELII;

EID: 33747784964     PISSN: 01666851     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molbiopara.2006.06.002     Document Type: Article

References (49)

1. Miller L.H., Baruch D.I., Marsh K., and Doumbo O.K. The pathogenic basis of malaria. Nature 415 (2002) 673-679
2. Galinsky M.R., Dluzewski A.R., and Barnwell J.W. A mechanistic approach to merozoite invasion of red blood cells: merozoite biogenesis, rupture, and invasion of erythrocytes. In: Sherman I.W. (Ed). Molecular approaches to malaria (2005), ASM Press, Washington, DC 113-168
3. Gaur D., Mayer D.C., and Miller L.H. Parasite ligand-host receptor interactions during invasion of erythrocytes by Plasmodium merozoites. Int J Parasitol 34 (2004) 1413-1429
4. Dolan S.A., Miller L.H., and Wellems T.W. Evidence for a switching mechanism in the invasion of erythrocytes by Plasmodium falciparum. J Clin Invest 86 (1990) 618-624
5. Hadley T.J., Klotz F.W., Pasvol G., et al. Falciparum malaria parasites invade erythrocytes that lack glycophorin A and B (MkMk). Strain differences indicate receptor heterogeneity and two pathways for invasion. J Clin Invest 80 (1987) 1190-1193
6. Mitchell G.H., Hadley T.J., McGinniss M.H., Klotz F.W., and Miller L.H. Invasion of erythrocytes by Plasmodium falciparum malaria parasites: evidence for receptor heterogeneity and two receptors. Blood 67 (1986) 1519-1521
7. Sim B.K.L., Chitnis C.E., Wasniowska K., Hadley T.J., and Miller L.H. Receptor and ligand domains for invasion of erythrocytes by Plasmodium falciparum. Science 264 (1994) 1941-1944
8. Stubbs J., Simpson K.M., Triglia T., et al. Molecular mechanism for switching of P. falciparum invasion pathways into human erythrocytes. Science 309 (2005) 1384-1387
9. Swardson-Olver C.J., Dawson T.C., Burnett R.C., Peiper S.C., Maeda N., and Avery A.C. Plasmodium yoelii uses the murine Duffy antigen receptor for chemokines as a receptor for normocyte invasion and an alternative receptor for reticulocyte invasion. Blood 99 (2002) 2677-2684
10. 19 across distantly related Plasmodium species. Nat Med 6 (2000) 91-95
11. Holder A.A., and Freeman R.R. The three major antigens on the surface of Plasmodium falciparum merozoites are derived from a single high molecular weight precursor. J Exp Med 160 (1984) 624-629
12. Lyon J.A., Geller R.H., Haynes J.D., Chulay J.D., and Weber J.L. Epitope map and processing scheme for the 195,000-dalton surface glycoprotein of Plasmodium falciparum merozoites deduced from cloned overlapping segments of the gene. Proc Natl Acad Sci USA 83 (1986) 2989-2993
13. r 185,000 glycoprotein from the surface of isolated Plasmodium falciparum merozoites form an antigenic complex. Mol Biochem Parasitol 23 (1987) 71-84
14. Trucco C., Fernandez-Reyes D., Howell S., et al. The merozoite surface protein 6 gene codes for a 36 kDa protein associated with the Plasmodium falciparum merozoite surface protein-1 complex. Mol Biochem Parasitol 112 (2001) 91-101
15. Pachebat J.A., Ling I.T., Grainger M., et al. The 22 kDa component of the protein complex on the surface of Plasmodium falciparum merozoites is derived from a larger precursor, merozoite surface protein 7. Mol Biochem Parasitol 117 (2001) 83-89
16. Mello K., Daly T.M., Morrisey J., Vaidya A.B., Long C.A., and Bergman L.W. A multigene family that interacts with the amino terminus of Plasmodium MSP-1 identified using the yeast two-hybrid system. Eukaryot Cell 1 (2002) 915-925
17. Perkins M.E., and Rocco L.J. Sialic acid-dependent binding of Plasmodium falciparum merozoite surface antigen, Pf200, to human erythrocytes. J Immunol 141 (1988) 3190-3196
18. Goel V.K., Li X., Chen H., Liu S.C., Chishti A.H., and Oh S.S. Band 3 is a host receptor binding merozoite surface protein 1 during the Plasmodium falciparum invasion of erythrocytes. Proc Natl Acad Sci USA 100 (2003) 5164-5169
19. Blackman M.J., Heidrich H.G., Donachie S., McBride J.S., and Holder A.A. A single fragment of a malaria merozoite surface protein remains on the parasite during red cell invasion and is the target of invasion-inhibiting antibodies. J Exp Med 172 (1990) 379-382
20. Daly T.M., and Long C.A. Humoral response to a carboxyl-terminal region of the merozoite surface protein-1 plays a predominant role in controlling blood-stage infection in rodent malaria. J Immunol 155 (1995) 236-243
21. Kumar S., Yadava A., Keister D.B., et al. Immunogenicity and in vivo efficacy of recombinant Plasmodium falciparum merozoite surface protein-1 in Aotus monkeys. Mol Med 1 (1995) 325-332
22. 19, the carboxyl terminal fragment of the major merozoite surface protein of Plasmodium falciparum. Infect Immun 63 (1995) 456-466
23. 19) of Plasmodium yoelii expressed in Saccharomyces cerevisiae. J Immunol 159 (1997) 3400-3411
24. 19 are a major component of the invasion-inhibitory response in individuals immune to malaria. J Exp Med 193 (2001) 1403-1412
25. Burns Jr. J.M., Belk C.C., and Dunn P.D. A protective glycosylphosphatidylinositol- anchored membrane protein of Plasmodium yoelii trophozoites and merozoites contains two epidermal growth factor-like domains. Infect Immun 68 (2000) 6189-6195
26. Shi Q., Cernetich A., Daly T.M., et al. Alteration in host cell tropism limits the efficacy of immunization with a surface protein of malaria merozoites. Infect Immun 73 (2005) 6363-6371
27. Black C.G., Wu T., Wang L., Hibbs A.R., and Coppel R.L. Merozoite surface protein 8 of Plasmodium falciparum contains two epidermal growth factor-like domains. Mol Biochem Parasitol 114 (2001) 217-226
28. Drew D.R., Sanders P.R., and Crabb B.S. Plasmodium falciparum merozoite surface protein 8 is a ring-stage membrane protein that localizes to the parasitophorous vacuole of infected erythrocytes. Infect Immun 73 (2005) 3912-3922
29. Black C.G., Wu T., Wang L., Topolska A.E., and Coppel R.L. MSP-8 is a non-essential merozoite surface protein in Plasmodium falciparum. Mol Biochem Parasitol 144 (2005) 27-35
30. Puentes A., García J., Ocampo M., et al. P. falciparum: merozoite surface protein-8 peptides bind specifically to human erythrocytes. Peptides 24 (2003) 1015-1023
31. Perez-Leal O., Sierra A.Y., Barrero C.A., et al. Plasmodium vivax merozoite surface protein 8 cloning, expression, and characterization. Biochem Biophys Res Commun 324 (2004) 1393-1399
32. Drew D.R., O'Donnell R.A., Smith B.J., and Crabb B.S. A common cross-species function for the double epidermal growth factor-like modules of the highly divergent plasmodium surface proteins MSP-1 and MSP-8. J Biol Chem 279 (2004) 20147-20153
33. Burns Jr. J.M., Majarian W.R., Young J.F., Daly T.M., and Long C.A. A protective monoclonal antibody recognizes an epitope in the carboxyl-terminal cysteine-rich domain in the precursor of the major merozoite surface antigen of the rodent malarial parasite, Plasmodium yoelii. J Immunol 143 (1989) 2670-2676
34. Fahey J.R., and Spitalny G.L. Virulent and nonvirulent forms of Plasmodium yoelii are not restricted to growth within a single erythrocyte type. Infect Immun 44 (1984) 151-156
35. Maier A.G., Duraisingh M.T., Reeder J.C., et al. Plasmodium falciparum erythrocyte invasion through glycophorin C and selection for Gerbich negativity in human populations. Nat Med 9 (2003) 87-92
36. Fairbanks G., Steck T.L., and Wallach D.F.H. Electrophoretic analysis of the major polypeptides of the human erythrocyte membrane. Biochemistry 10 (1971) 2606-2617
37. Holder A.A., Freeman R.R., and Nicholls S.C. Immunization against Plasmodium falciparum with recombinant polypeptides produced in Escherichia coli. Parasite Immunol 10 (1988) 607-617
38. Chang S.P., Case S.E., Gosnell W.L., et al. A recombinant baculovirus 42-kilodalton C-terminal fragment of Plasmodium falciparum merozoite surface protein 1 protects Aotus monkeys against malaria. Infect Immun 64 (1996) 253-261
39. Yang C., Collins W.E., Sullivan J.S., Kaslow D.C., Xiao L., and Lal A.A. Partial protection against Plasmodium vivax blood-stage infection in Saimiri monkeys by immunization with a recombinant C-terminal fragment of merozoite surface protein 1 in block copolymer adjuvant. Infect Immun 67 (1999) 342-349
40. Stowers A.W., Cioce V., Shimp V.L., et al. Efficacy of two alternate vaccines based on Plasmodium falciparum merozoite surface protein 1 in an Aotus challenge trial. Infect Immun 69 (2001) 1536-1546
41. Kedzierski L., Black C.G., Goschnick M.W., Stowers A.W., and Coppel R.L. Immunization with a combination of merozoite surface proteins 4/5 and 1 enhances protection against lethal challenge with Plasmodium yoelii. Infect Immun 70 (2002) 6606-6613
42. Mello K., Daly T.M., Long C.A., Burns Jr. J.M., and Bergman L.W. Members of the merozoite surface protein 7 family with similar expression patterns differ in ability to protect against Plasmodium yoelii malaria. Infect Immun 72 (2004) 1010-1018
43. Epstein N., Miller L.H., Kaushel D.C., et al. Monoclonal antibodies against a specific surface determinant on malarial (Plasmodium knowlesi) merozoites block erythrocyte invasion. J Immunol 127 (1981) 212-217
44. Miller L.H., David P.H., Hudson D.E., Hadley T.J., Richards R.L., and Aikawa M. Monoclonal antibodies to a 140,000-m.w. protein on Plasmodium knowlesi merozoites inhibit their invasion of rhesus erythrocytes. J Immunol 132 (1984) 438-442
45. Chappel J.A., and Holder A.A. Monoclonal antibodies that inhibit Plasmodium falciparum invasion in vitro recognize the first growth factor-like domain of merozoite surface protein-1. Mol Biochem Parasitol 60 (1993) 303-311
46. Su S., Sanadi A.R., Ifon E., and Davidson E.A. A monoclonal antibody capable of blocking the binding of Pf200 (MSA-1) to human erythrocytes and inhibiting the invasion of Plasmodium falciparum merozoites into human erythrocytes. J Immunol 151 (1993) 2309-2317
47. Li X., Chen H., Oo T.H., et al. A co-ligand complex anchors Plasmodium falciparum merozoites to the erythrocyte invasion receptor band 3. J Biol Chem 279 (2004) 5765-5771
48. Nikodem D.P., and Davidson E.A. Identification of a novel antigenic domain of Plasmodium falciparum merozoite surface protein-1 that specifically binds to human erythrocytes and inhibits parasite invasion, in vitro. Mol Biochem Parasitol 108 (2000) 79-91
49. Ogun S.A., Scott-Finnigan T.J., Narum D.L., and Holder A.A. Plasmodium yoelii: effects of red blood cell modification and antibodies on the binding characteristics of the 235 kDa rhoptry protein. Exp Parasitol 95 (2000) 187-195